Edition:
United States

Clinigen Group PLC (CLINC.L)

CLINC.L on London Stock Exchange

810.00GBp
24 Jan 2017
Change (% chg)

-2.00 (-0.25%)
Prev Close
812.00
Open
790.00
Day's High
814.00
Day's Low
790.00
Volume
306,298
Avg. Vol
496,691
52-wk High
827.50
52-wk Low
492.75

CLINC.L

Chart for CLINC.L

About

Clinigen Group plc is a United Kingdom-based pharmaceutical and services company. The Company's principal activities include management, sale and distribution of pharmaceutical products, which have associated expiry dates. The Company operates through five segments: Clinigen Clinical Trial Services (CTS), which sources... (more)

Overall

Beta: 0.60
Market Cap(Mil.): £934.57
Shares Outstanding(Mil.): 115.09
Dividend: 2.70
Yield (%): --

Financials

  CLINC.L Industry Sector
P/E (TTM): 69.04 44.03 29.85
EPS (TTM): 0.12 -- --
ROI: 4.88 -1.39 14.85
ROE: 6.12 -1.05 16.28

BRIEF-Clinigen group says CEO peter george to step down

* Shaun Chilton, current deputy CEO, will become CEO on that date Source text for Eikon: Further company coverage: (Bengaluru Newsroom)

Sep 28 2016

BRIEF-Clinigen Group reports FY reported revenue 339.9 mln stg

* Clinigen group plc: transformational year delivers 25% growth in adjusted EPS

Sep 28 2016

BRIEF-Clinigen and Cumberland Pharmaceuticals launch dry mouth drug in U.S

* Clinigen GrouE and Cumberland Pharmaceuticals launch Rthyol in U.S Source text for Eikon: Further company coverage:

Sep 26 2016

Earnings vs. Estimates